Intracerebroventricular administration of β-endorphin increases the expression of c-fos and of corticotropin-releasing factor messenger ribonucleic acid in the paraventricular nucleus of the rat

Brain Research

Volumn 707, Issue 2, 1996, Pages 189-195

  Wang, Xiao Quan ^a   Imaki, Toshihiro ^a   Shibasaki, Tamotsu ^a   Yamauchi, Naoko ^a   Demura, Hiroshi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

C fos; Corticotropin releasing factor; Hypothalamic pituitary adrenal axis; In situ hybridization; Opioid peptide

Indexed keywords

BETA ENDORPHIN; CORTICOTROPIN RELEASING FACTOR; MESSENGER RNA; NALOXONE; OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IN SITU HYBRIDIZATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RAT; THALAMUS MIDLINE NUCLEUS;

EID: 0029670699     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(95)01234-6     Document Type: Article

References (32)

1. Buckingham, J.C. and Cooper, T.A., Differences in hypothalamopituitary-adrenocortical activity in the rat after acute and prolonged treatment with morphine, Neuroendocrinology, 38 (1984) 411-427.
2. Buckingham, J.C. and Cooper, T.A., Effects of naloxone on hypothalamo-pituitary-adrenocortical activity, Neuroendocrinology, 42 (1986) 421-426.
3. Curran, T., Fos and Jun: intermediary transcription factors. In: P. Cohen and J.G. Foulkers (Eds.), The Hormonal Control Regulation of Gene Transcription, 1991, pp. 295-308.
4. 2-met-enkephalinamide, a potent opioid peptide, alters pituitary-adrenocortical secretion in rats, Endocrinology, 111 (1982) 1483-1490.
5. Domansli, E., Romanowicz, K. and Kerdelhue, B., Enhancing effect of intracerebrally infused β-endorphin antiserum on the secretion of Cortisol in foot-shocked sheep, Neuroendocrinology, 57 (1993) 127-131.
6. 5)-enkephalinamide on CRF and ACTH secretion, Peptides, 8 (1987) 113-118.
7. Imaki, T., Shibasaki, T., Hotta, M., Masuda, A., Demura, H., Shizume, K. and Ling, N., The satiety effect of growth hormone releasing factor in rats, Brain Research, 340 (1985) 186-188.
8. Imaki, T., Shibasaki, T., Masuda, A., Hotta, M., Yamauchi, N., Demura, H., Shizume, K., Wakabayashi, I. and Ling, N., The effect of glucose and free fatty acids on growth hormone (GH)-releasing factor-mediated GH secretion in rats, Endocrinology, 118 (1986) 2390-2394.
9. Imaki, T., Nahon, J.-L., Sawchenko, P.E. and Vale, W., Widespread expression of corticotropin-releasing factor messenger RNA and immunoreactivity in the rat olfactory bulb, Brain Research, 496 (1989) 35-44.
10. Imaki, T, Shibasaki, T., Hotta, M. and Demura, H., Early induction of c-fos precedes increased expression of corticotropin-releasing factor messenger ribonucleic acid in the paraventricular nucleus after immobilization stress, Endocrinology, 131 (1992) 240-246.
11. Imaki, T., Shibasaki, T., Hotta, M. and Demura, H., Intracerebroventricular administration of corticotropin-releasing factor induced c-fos mRNA expression in brain regions related to stress responses: comparison with pattern of c-fos mRNA induction after stress, Brain Research, 616 (1993) 114-125.
12. Imaki, T., Wang, X.-Q., Shibasaki, T., Harada, S., Chikada, N., Takahashi, C., Naruse, M. and Demura, H., Chlordiazepoxide attenuates stress-induced activation of neurons, corticotropin-releasing factor (CRF) gene transcription and CRF biosynthesis in the paraventricular nucleus (PVN). Mol. Brain Res., in press.
13. Mansour, A., Fox, C.A., Thompson, R.C., Akil, H. and Watson, S.J., μ-Opioid receptor mRNA expression in the rat CNS: comparison to μ-receptor binding, Brain Research, 643 (1994) 245-265.
14. McDonald, R.K., Evans, F.T., Weise, V.K. and Patrick, R.W., Effect of morphine and nalorphine on plasma hydrocortisone levels in man, J. Pharmacol. Exp. Ther., 125 (1959) 240.
15. Minami, S., Kamegai, J., Sugihara, H., Hasegawa, O. and Wakabayashi, I., Systemic administration of recombinant human growth hormone induces expression of the c-fos gene in the hypothalamic arcuate and periventricular nuclei in hypophysectomized rats, Endocrinology, 131 (1992) 247-253.
16. Morgan, J.I. and Curran, T., Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun, Annu. Rev. Neurosci., 14 (1991) 421-451.
17. Nicoll, R.A., Siggins, G.R., Ling, N., Bloom, F.E. and Guillemin, R., Neuronal actions of endorphins and enkephalins among brain regions. A comparative microiontophoretic study, Proc. Natl. Acad. Sci. USA, 74 (1977) 2584-2588.
18. Plotsky, P.M., Opioid inhibition of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation of rats, Regul. Pept., 16 (1986) 235-242.
19. Przekop, F., Mateusiak, K., Stupnicka, E., Romanowicz, K., Domanski, E., Suppressive effect of β-endorphin and naloxone on the secretion of cortisol under stress conditions in sheep, Exp. Clin. Endocrinol., 95 (1991) 210-216.
20. Sager, S.M., Sharp, F.R. and Curran, T., Expression of c-fos protein in brain: metabolic mapping at the cellular level, Science, 240 (1988) 1328-1331.
21. Sakanaka, M., Shibasaki, T. and Lederis, K., Corticotropin-releasing factor-like immunoreactivity in the rat brain as revealed by a modified cobalt-glucose oxidase-diaminobenzidine method, J. Comp. Neurol., 260 (1987) 256-298.
22. Seaholtz, A.F., Thompson, R.C. and Douglass, J.O., Identification of a cyclic adenosine monophosphate-responsive element in the rat corticotropin-releasing hormone gene, Mol. Endocrinol., 2 (1988) 1311-1319.
23. Shibasaki, T., Yamauchi, N., Kato, Y., Masuda, A., Imaki, T., Hotta, M., Demura, H., Oono, H., Ling, N. and Shizume, K., Involvement of corticotropin-releasing factor in restraint stress-induced anorexia and reversion of anorexia by somatostatin in the rat, Life Sci., 43 (1988) 1103-110.
24. Spengler, D., Rupprecht, R., Van, L.P. and Holsboer, F., Identification and characterization of a 3,5′-cyclic adenosine corticotropin-releasing hormone gene promoter, Mol. Endocrinol., 6 (1992) 1931-1941.
25. Suemaru, S., Dallman, M.F., Darlington, D.N., Cascio, C.S. and Shinsako, J., Role of alpha-adrenergic mechanism in effects of morphine on the hypothalamo-pituitary-adrenocortical and cardiovascular systems in the rat, Neuroendocrinology, 49 (1989) 181-190.
26. Tsagarakis, S., Navada, P., Rees L.H., Besser, M. and Grossman, A., Morphine directly modulates the release of stimulated corticotropin-releasing factor-41 from rat hypothalamus in vitro, Endocrinology, 124 (1989) 2330-2335.
27. Tsagarakis, S., Rees, L.H., Besser, M. and Grossman, A., Opiate receptor subtype regulation of CRF-41 release from rat hypothalamus in vitro, Neuroendocrinology, 51 (1990) 599-605.
28. Tsagarakis, S. and Grossman, A., Central neuroregulation of hypothalamic corticotropin-releasing hormone (CRH-41) secretion, J. Endocrinol. Invest., 13 (1990) 765-775.
29. Uhl, G.R., Childers, S. and Pasternak, G.P., An opiate-receptor gene family reunion, Trends Neurosci., 3 (1994) 89-93.
30. Volavka, J., Cho, D., Mallya, A. and Bauman, J., Naloxone increases ACTH and cortisol levels in man, New Engl. J. Med., 30 (1979) 1056-1058.
31. Yajima, F., Suda, T., Tomori, N., Sumitomo, Y., Nakagami, Y., Ushiyama, T., Demura, H. and Shizume, K., Effects of opioid peptides on immunoreactive corticotropin-releasing factor release from the rat hypothalamus in vitro, Life Sci., 39 (1986) 181-186.
32. Zastawny, R.L., George, S.R., Nguyen, T., Cheng, R., Tsatsos, J., Briones-Urbina, R. and O'Dowd, B.F. Cloning, characterization, and distribution of a μ-opioid receptor in rat brain, J. Neurochem., 62 (1994) 2099-2105.